Sustained Remission With Methotrexate Monotherapy After 22-Week Induction Treatment With TNF-alpha Inhibitor and Methotrexate in Early Psoriatic Arthritis: An Open-Label Extension of a Randomized Placebo-Controlled Trial
Arthritis Research & Therapy
doi 10.1186/s13075-019-1998-4
Full Text
Open PDFAbstract
Available in full text
Date
September 14, 2019
Authors
Publisher
Springer Science and Business Media LLC